Contact information
Research groups
Colleges
Nam Nguyen
Researcher in Health Economics
Dr Nam Nguyen has been a researcher at the Nuffield Department of Primary Care Health Sciences since February 2025. He previously worked at the Health Economics Research Centre (HERC) within the Nuffield Department of Population Health. His current research focuses on using large healthcare databases to investigate antibiotic prescribing in primary care and inform antibiotic stewardship interventions. He is also interested in applying new methods to enhance the use of big data, such as instrumental variable approaches to provide unbiased estimates of the causal effects of antibiotic prescribing. His work draws on large observational datasets from both high-income settings (e.g., the Clinical Practice Research Datalink – CPRD) and low-income settings (e.g., the IQVIA Medical Data Index (MDI) for Pakistan, Egypt, and Indonesia) to inform localised guidelines and antibiotic use targets globally.
Prior to joining Oxford, Nam was based at the Oxford University Clinical Research Unit (OUCRU) in Hanoi, Vietnam, where he completed his PhD focusing on community-level antimicrobial stewardship in low- and middle-income countries. His PhD research examined antibiotic use patterns in Vietnamese primary care settings and the feasibility of implementing point-of-care testing in private pharmacies to reduce over-the-counter antibiotic sales.
Earlier in his career, Nam was a university lecturer in pharmacoepidemiology and pharmacoeconomics at the Hanoi University of Pharmacy in Vietnam. He also served as a pharmacovigilance consultant to the Vietnamese Ministry of Health and is a registered pharmacist in Vietnam. He holds a PhD in Life and Health Sciences from the Open University–Oxford University Clinical Research Unit affiliated doctoral programme, and an MSc in Medicines Risk-Benefit Assessment from the European Education and Training Programme in Pharmacovigilance and Pharmacoepidemiology (Eu2P).
Recent publications
Benchmarking AWaRe: estimating optimal levels of AWaRe antibiotic use in 186 countries, territories and areas based on clinical infection and resistance burden.
Journal article
POUWELS K. et al, (2026), The Lancet Public Health
AWaRe antibiotic prescribing for common acute infections in private primary care in low-middle-income countries: a patient-level analysis using IQVIA prescriber surveys from Pakistan, Egypt and Indonesia.
Journal article
Nguyen N. et al, (2026), BMJ Glob Health, 11
Advancing monitoring of antimicrobial resistance trajectories using flexible spatiotemporal modelling: a change-point analysis
Journal article
Allel K. et al, (2025)
Determinants of antibiotic prescribing in primary care in Vietnam: a qualitative study using the Theoretical Domains Framework
Journal article
Vu Minh D. et al, (2024), Antimicrobial Resistance and Infection Control, 13